Pfizer Raises Outlook Amid Strong Demand for Non-Covid Products
Wall Street Journal
The drugmaker’s quarterly results beat Wall Street estimates and the drugmaker raised its outlook, denoting strong demand for its non-Covid products.
Understanding current events through the lenses of the past and future.
Wall Street Journal
The drugmaker’s quarterly results beat Wall Street estimates and the drugmaker raised its outlook, denoting strong demand for its non-Covid products.